{
  "request": {
    "url": "https://query2.finance.yahoo.com/ws/insights/v2/finance/insights?lang=en-US&region=US&getAllResearchReports=true&reportsCount=2&symbol=CRON"
  },
  "response": {
    "ok": true,
    "status": 200,
    "statusText": "OK",
    "headers": {
      "content-type": [
        "application/json;charset=utf-8"
      ],
      "cache-control": [
        "public, max-age=300, stale-while-revalidate=120"
      ],
      "vary": [
        "Origin,Accept-Encoding"
      ],
      "y-rid": [
        "9v93oklh29j2j"
      ],
      "x-yahoo-request-id": [
        "9v93oklh29j2j"
      ],
      "x-request-id": [
        "aab68ec9-65c7-4bee-a23d-e2bc50442078"
      ],
      "content-encoding": [
        "gzip"
      ],
      "content-length": [
        "2266"
      ],
      "x-envoy-upstream-service-time": [
        "6"
      ],
      "date": [
        "Sun, 06 Mar 2022 14:59:31 GMT"
      ],
      "server": [
        "ATS"
      ],
      "x-envoy-decorator-operation": [
        "finance-market-analytics-api--mtls-production-ir2.finance-k8s.svc.yahoo.local:4080/*"
      ],
      "age": [
        "0"
      ],
      "strict-transport-security": [
        "max-age=15552000"
      ],
      "referrer-policy": [
        "no-referrer-when-downgrade"
      ],
      "x-frame-options": [
        "SAMEORIGIN"
      ],
      "connection": [
        "close"
      ],
      "expect-ct": [
        "max-age=31536000, report-uri=\"http://csp.yahoo.com/beacon/csp?src=yahoocom-expect-ct-report-only\""
      ],
      "x-xss-protection": [
        "1; mode=block"
      ],
      "x-content-type-options": [
        "nosniff"
      ]
    },
    "bodyJson": {
      "finance": {
        "result": {
          "symbol": "CRON",
          "instrumentInfo": {
            "technicalEvents": {
              "provider": "Trading Central",
              "sector": "Healthcare",
              "shortTermOutlook": {
                "stateDescription": "Recent bearish events outweigh bullish events.",
                "direction": "Bearish",
                "score": 3,
                "scoreDescription": "Strong Bearish Evidence",
                "sectorDirection": "Bullish",
                "sectorScore": 3,
                "sectorScoreDescription": "Strong Bullish Evidence",
                "indexDirection": "Bearish",
                "indexScore": 1,
                "indexScoreDescription": "Weak Bearish Evidence"
              },
              "intermediateTermOutlook": {
                "stateDescription": "Recent bullish events outweigh bearish events.",
                "direction": "Bullish",
                "score": 1,
                "scoreDescription": "Weak Bullish Evidence",
                "sectorDirection": "Bearish",
                "sectorScore": 1,
                "sectorScoreDescription": "Weak Bearish Evidence",
                "indexDirection": "Bearish",
                "indexScore": 3,
                "indexScoreDescription": "Strong Bearish Evidence"
              },
              "longTermOutlook": {
                "stateDescription": "All events are bearish.",
                "direction": "Bearish",
                "score": 1,
                "scoreDescription": "Weak Bearish Evidence",
                "sectorDirection": "Bullish",
                "sectorScore": 2,
                "sectorScoreDescription": "Bullish Evidence",
                "indexDirection": "Bearish",
                "indexScore": 2,
                "indexScoreDescription": "Bearish Evidence"
              }
            },
            "keyTechnicals": {
              "provider": "Trading Central",
              "support": 3.11,
              "resistance": 5.495,
              "stopLoss": 2.644775
            },
            "valuation": {
              "color": 0,
              "description": "Overvalued",
              "relativeValue": "Premium",
              "provider": "Trading Central"
            }
          },
          "companySnapshot": {
            "sectorInfo": "Healthcare",
            "company": {
              "innovativeness": 0.1496,
              "insiderSentiments": 0.2975,
              "earningsReports": 0.36310000000000003
            },
            "sector": {
              "innovativeness": 0.5,
              "hiring": 0.5,
              "sustainability": 0.5,
              "insiderSentiments": 0.5,
              "earningsReports": 0.5,
              "dividends": 0.5
            }
          },
          "upsell": {
            "msBullishSummary": [
              "Altria Groupâ€™s investment of $1.8 billion provides Cronos with capital and a strategic partner with significant product development, branding, and regulatory experience. If successful, Altria Group may increase its ownership of Cronos or potentially acquire it.",
              "Altria's distribution network gives Cronos an advantage in the hyper competitive U.S. CBD market and can be leveraged for eventual THC distribution.",
              "Cronos' option to acquire 10.5% of U.S. multistate operator PharmaCann gives U.S. THC investment exposure and a hedge if the dispensary model persists."
            ],
            "msBearishSummary": [
              "Cronos' small size adds difficulty to reaching profitability, as it struggles to leverage overhead expenses.",
              "Even upon the removal of federal prohibition, THC distribution will never look like alcohol and tobacco, weakening Cronos' U.S. strategy.",
              "Provinces and countries are incentivized to maximize tax revenue for products like alcohol, tobacco, and cannabis. Although alcohol and tobacco companies successfully pass higher taxes onto consumers, cannabis companies lack the brand power to do the same."
            ],
            "companyName": "Cronos Group Inc. Common Share",
            "msBullishBearishSummariesPublishDate": 1646197749000,
            "upsellReportType": "MORNINGSTAR_ANALYST"
          },
          "upsellSearchDD": {
            "researchReports": {
              "reportId": "MS_0P00018572_AnalystReport_1646197749000",
              "provider": "Morningstar",
              "title": "Cutting Cronos' Fair Value Estimate as Its Smaller Size Limits Its Ability to Scale to Profitability",
              "reportDate": "2022-03-02T05:09:09Z",
              "summary": "Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann. ",
              "investmentRating": "Bullish"
            }
          },
          "events": [
            {
              "eventType": "Slow Stochastic",
              "pricePeriod": "D",
              "tradingHorizon": "S",
              "tradeType": "L",
              "imageUrl": "https://s.yimg.com/uc/fin/img/assets/generic.svg",
              "startDate": 1646058600,
              "endDate": 1646058600
            }
          ],
          "reports": [
            {
              "id": "MS_0P00018572_AnalystReport_1646197749000",
              "headHtml": "Analyst Report: Cronos Group Inc.",
              "provider": "Morningstar",
              "reportDate": "2022-03-02T05:09:09Z",
              "reportTitle": "Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann. ",
              "reportType": "Analyst Report",
              "targetPrice": 5,
              "targetPriceStatus": "Decreased",
              "investmentRating": "Bullish"
            },
            {
              "id": "MS_0P00018572_AnalystReport_1645227107000",
              "headHtml": "Analyst Report: Cronos Group Inc.",
              "provider": "Morningstar",
              "reportDate": "2022-02-18T23:31:47Z",
              "reportTitle": "Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann. ",
              "reportType": "Analyst Report",
              "targetPrice": 6,
              "targetPriceStatus": "Decreased",
              "investmentRating": "Bullish"
            }
          ],
          "sigDevs": [
            {
              "headline": "Cronos Group Reports 2021 Fourth Quarter And Full-Year Results",
              "date": "2022-03-01"
            }
          ],
          "secReports": [
            {
              "id": "0001656472-22-000034_1656472",
              "type": "Periodic Financial Reports",
              "title": "10-K : Periodic Financial Reports",
              "description": "Annual report pursuant to Section 13 and 15(d)",
              "filingDate": 1646092800000,
              "snapshotUrl": "https://cdn.yahoofinance.com/prod/sec-reports-thumbnails/0001656472/000165647222000034/thumbnail.png",
              "formType": "10-K"
            },
            {
              "id": "0001656472-22-000033_1656472",
              "type": "Corporate Changes & Voting Matters",
              "title": "8-K : Corporate Changes & Voting Matters",
              "description": "Current report filing",
              "filingDate": 1646092800000,
              "snapshotUrl": "https://cdn.yahoofinance.com/prod/sec-reports-thumbnails/0001656472/000165647222000033/thumbnail.png",
              "formType": "8-K"
            },
            {
              "id": "0001656472-22-000018_1656472",
              "type": "Periodic Financial Reports",
              "title": "NT 10-Q/A : Periodic Financial Reports",
              "description": "Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB",
              "filingDate": 1645142400000,
              "snapshotUrl": "https://cdn.yahoofinance.com/prod/sec-reports-thumbnails/0001656472/000165647222000018/thumbnail.png",
              "formType": "NT 10-Q/A"
            },
            {
              "id": "0001656472-22-000023_1656472",
              "type": "Periodic Financial Reports",
              "title": "10-Q : Periodic Financial Reports",
              "description": "Quarterly report pursuant to Section 13 or 15(d)",
              "filingDate": 1645142400000,
              "snapshotUrl": "https://cdn.yahoofinance.com/prod/sec-reports-thumbnails/1656472/000165647222000023/thumbnail.png",
              "formType": "10-Q"
            },
            {
              "id": "0001656472-22-000020_1656472",
              "type": "Corporate Changes & Voting Matters",
              "title": "8-K : Corporate Changes & Voting Matters",
              "description": "Current report filing",
              "filingDate": 1645142400000,
              "snapshotUrl": "https://cdn.yahoofinance.com/prod/sec-reports-thumbnails/1656472/000165647222000020/thumbnail.png",
              "formType": "8-K"
            },
            {
              "id": "0001656472-22-000021_1656472",
              "type": "Periodic Financial Reports",
              "title": "10-Q/A : Periodic Financial Reports",
              "description": "Quarterly report pursuant to Section 13 or 15(d)",
              "filingDate": 1645142400000,
              "snapshotUrl": "https://cdn.yahoofinance.com/prod/sec-reports-thumbnails/1656472/000165647222000021/thumbnail.png",
              "formType": "10-Q/A"
            }
          ]
        },
        "error": null
      }
    }
  }
}